The University of Chicago Header Logo

Connection

Wendy Stock to HLA-DR Antigens

Back to Details
This is a "connection" page, showing publications Wendy Stock has written about HLA-DR Antigens.
Wendy Stock
Connection Strength
0.022
HLA-DR Antigens
  1. A phase I/II dose escalation study of apolizumab (Hu1D10) using a stepped-up dosing schedule in patients with chronic lymphocytic leukemia and acute leukemia. Leuk Lymphoma. 2009 Dec; 50(12):1958-63.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.